Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07126652) titled 'Serological Responses to Adjuvanted Versus Non-adjuvanted Influenza Vaccines Among People With HIV: a Randomized Clinical Trial' on Aug. 11.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: None (Open Label).

Primary Sponsor: National Taiwan University Hospital

Condition: Antibody Response

Intervention: Drug: MF-59 Drug: cell-based

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: October 1, 2025

Target Sample Size: 300

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07126652

Disc...